文献速递产科麻醉术前评估与围术期医学

剖宫产鞘内吗啡后连续二氧化碳监测与脉搏血氧监测的前瞻性观察研究

Prospective Observational Investigation of Capnography and Pulse Oximetry Monitoring After Cesarean Delivery With Intrathecal Morphine.
PubMed 文献 · Anesth Analg · 2019-01-01

前瞻性观察80例择期剖宫产接受150微克鞘内吗啡的产妇,连续24小时二氧化碳监测和脉搏血氧监测。共记录198次呼吸暂停警报事件(AAE),53%产妇发生,护士每小时呼吸频率观察未发现这些呼吸暂停,无临床相关不良事件,但82%产妇对鼻采样管有不适主诉。

要点

  • 鞘内吗啡剖宫产后53%产妇出现呼吸暂停警报事件,护士每小时观察未能发现。
  • 连续二氧化碳监测可发现间歇观察漏掉的呼吸暂停,但真假呼吸暂停无法区分。
  • 82%产妇对鼻采样管有不适主诉,可能影响剖宫产后二氧化碳监测的临床应用。

核心结论

  • 剖宫产鞘内吗啡后连续二氧化碳监测记录到198次呼吸暂停警报事件,但无临床相关不良事件。
  • 护士每小时呼吸频率观察未能确认这些呼吸暂停,无法区分真实但无临床意义的警报与假性呼吸暂停。

研究设计与样本

  • 前瞻性观察性研究,经机构审查委员会批准,纳入80例接受150微克鞘内吗啡腰麻剖宫产的产妇。
  • 所有产妇进行STOP-Bang阻塞性睡眠呼吸暂停评估,要求剖宫产后连续使用二氧化碳监测和脉搏血氧监测24小时。

主要发现

  • 共招募80例产妇,平均(标准差)年龄35(5)岁,47%体重指数>30 kg/m2或体重>90 kg,11%疑似阻塞性睡眠呼吸暂停。
  • 正常二氧化碳监测和脉搏血氧监测数据持续时间分别为平均(标准差)(范围)8:28(7:51)(0:00-22:32)和15:08(6:42)(1:31-23:07)小时:分钟,6例产妇未使用二氧化碳监测。
  • 共记录198次呼吸暂停警报事件,平均(标准差)持续时间57(27)秒,39/74(53%)产妇发生,每例中位数(中位数95%置信区间)(范围)为1(0-1)(0-29)次。
  • 护士所有时间点观察呼吸频率≥14次/分,二氧化碳监测与护士呼吸频率的相关系数r=0.05(95%置信区间-0.04至0.14)。

临床怎么用

  • 剖宫产鞘内吗啡后应考虑连续二氧化碳监测以发现间歇观察漏掉的呼吸暂停。
  • 需权衡二氧化碳监测的获益与鼻采样管不适及频繁警报对产妇的影响。

局限性

  • 缺乏观察者验证,无法区分真实但无临床意义的警报与假性呼吸暂停。
  • 6例产妇未使用二氧化碳监测,二氧化碳监测数据持续时间短于脉搏血氧监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intrathecal morphine provides excellent analgesia after cesarean delivery; however, respiratory events such as apnea, bradypnea, and hypoxemia have been reported. The primary study aim was to estimate the number of apneas per subject, termed "apnea alert events" (AAEs) defined by no breath for 30-120 seconds, using continuous capnography in women who underwent cesarean delivery. METHODS: We performed a prospective, observational study with institutional review board approval of women who underwent cesarean delivery with spinal anesthesia containing 150-µg intrathecal morphine. A STOP-Bang obstructive sleep apnea assessment was administered to all women. Women were requested to use continuous capnography and pulse oximetry for 24 hours after cesarean delivery. Nasal sampling cannula measured end-tidal carbon dioxide (EtCO2) and respiratory rate (RR), and oxygen saturation (SpO2) as measured by pulse oximetry. Capnography data were defined as "valid" when EtCO2 >10 mm Hg, RR >5 breaths per minute (bpm), SpO2 >70%, or during apnea (AAE) defined as "no breath" (EtCO2, <5 mm Hg) for 30-120 seconds. Individual respiratory variable alerts were 10-second means of EtCO2 <10 mm Hg, RR <8 bpm, and SpO2 <94%. Nurse observations of RR (hourly and blinded to capnography) are reported. RESULTS: We recruited 80 women, mean (standard deviation [SD]) 35 (5) years, 47% body mass index >30 kg/m2/weight >90 kg, and 11% with suspected obstructive sleep apnea (known or STOP-Bang score >3). The duration of normal capnography and pulse oximetry data was mean (SD) (range) 8:28 (7:51) (0:00-22:32) and 15:08 (6:42) (1:31-23:07) hours:minutes, respectively; 6 women did not use the capnography. There were 198 AAEs, mean (SD) duration 57 (27) seconds experienced by 39/74 (53%) women, median (95% confidence interval for median) (range) 1 (0-1) (0-29) per subject. Observation of RR by nurses was ≥14 bpm at all time-points for all women, r = 0.05 between capnography and nurse RR (95% confidence interval, -0.04 to 0.14). There were no clinically relevant adverse events for any woman. Sixty-five women (82%) had complaints with the capnography device, including itchy nose, nausea, interference with nursing baby, and overall inconvenience. CONCLUSIONS: We report 198 AAEs detected by capnography among women who underwent cesarean delivery after receiving intrathecal morphine. These apneas were not confirmed by the intermittent hourly nursing observations. Absence of observer verification precludes distinction between real, albeit nonclinically significant alerts with capnography versus false apneas. Discomfort with the nasal sampling cannula and frequent alerts may impact capnography application after cesarean delivery. No clinically relevant adverse events occurred.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Weiniger CF, Akdagli S, Turvall E, et al. Prospective Observational Investigation of Capnography and Pulse Oximetry Monitoring After Cesarean Delivery With Intrathecal Morphine. Anesth Analg. 2019. PMID: 29958217. doi:10.1213/ANE.0000000000003503

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。